|
Market Closed -
Hong Kong S.E.
04:08:13 2026-09-22 EDT
|
5-day change | 1st Jan Change | ||
| 29.40 HKD | +4.33% |
|
+14.93% | -15.81% |
| 08-27 | CanSino Biologics Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-26 | CanSino Biologics, deepGeneAI Agree to Develop Personalized mRNA Cancer Vaccines | MT |
| Market Cap | 12.45B 14.58B 1.86B 1.62B 1.53B 1.39B 2.61B 178B 2.61B 18.32B 7.07B 90.73B 6.98B 6.83B 292B | P/E 2026 * |
57.6x | P/E 2027 * | 19.3x |
|---|---|---|---|---|---|
| Enterprise Value | 12.48B 14.61B 1.86B 1.63B 1.53B 1.4B 2.62B 178B 2.62B 18.36B 7.08B 90.9B 6.99B 6.84B 293B | EV / Sales 2026 * |
8.66x | EV / Sales 2027 * | 7.1x |
| Free-Float |
39.3% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 6185 | Delayed | |
Tradegate
| CJH | Real-time | |
|
OTC Markets
| CASB.F | Delayed | |
|
Börse Stuttgart
| CJH | Delayed | |
|
Deutsche Boerse AG
| CJH | Delayed | |
|
Boerse Muenchen
| CJH | Real-time |
| 1 day | +4.33% | ||
| 1 week | +14.93% | ||
| Current month | -0.34% | ||
| 1 month | -0.27% | ||
| 3 months | +33.64% | ||
| 6 months | -11.34% | ||
| Current year | -15.81% |
| 1 week | 25.34 |  | 31.34 |
| 1 month | 25.08 | | 38.14 |
| Current year | 19.22 | | 41.64 |
| 1 year | 19.22 | | 53.45 |
| 3 years | 14.8 | | 56.55 |
| 5 years | 14.8 | | 289.4 |
| 10 years | 14.8 | | 450 |
| Manager | Title | Age | Since |
|---|---|---|---|
Dong Xu Qiu
PRN | Corporate Officer/Principal | 66 | 2024-02-20 |
Hui Hua Mao
PRN | Corporate Officer/Principal | 64 | 2009-01-12 |
Tao Zhu
CTO | Chief Tech/Sci/R&D Officer | 53 | 2009-01-12 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Yu
CHM | Chairman | 62 | 2009-01-12 |
Zhong Qi Shao
BRD | Director/Board Member | 63 | 2021-05-27 |
Shou Bai Chao
BRD | Director/Board Member | 63 | 2018-06-21 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 8/26/25 | Sell | Director | 4,600 | 0.0069% | ||
| 9/26/24 | Other | Chief Executive Officer | 20,000 | 0.0151% | ||
| 9/9/24 | Other | Founder | 30,000 | 0.0226% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.33% | +14.93% | -42.13% | +23.27% | 1.71B | |
| +0.72% | +3.85% | +34.96% | -2.54% | 79.7B | |
| +5.56% | +26.98% | +587.35% | +82.58% | 69.04B | |
| -0.38% | +3.37% | -9.83% | -28.74% | 60.82B | |
| -0.78% | -1.49% | -11.82% | +28.69% | 47.16B | |
| +0.66% | +1.72% | +3.39% | +159.99% | 46.38B | |
| +2.87% | +4.25% | +60.22% | -12.54% | 32.37B | |
| +1.83% | +4.26% | +49.81% | +118.47% | 25.27B | |
| +0.68% | +8.53% | +8.87% | +175.30% | 22.72B | |
| +1.04% | +1.96% | +59.16% | +103.91% | 15.7B | |
| Average | +1.16% | +5.49% | +74.00% | +64.84% | 40.09B | |
| Weighted average by Cap. | +0.63% | +6.98% | +116.26% | +51.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.44B 1.69B 215M 188M 177M 161M 302M 20.55B 302M 2.12B 818M 10.49B 807M 790M 33.83B | 1.81B 2.12B 270M 236M 222M 203M 380M 25.86B 381M 2.67B 1.03B 13.2B 1.02B 993M 42.57B |
| Net income | 107M 125M 15.97M 13.96M 13.12M 11.97M 22.47M 1.53B 22.47M 157M 60.75M 780M 59.97M 58.66M 2.51B | 322M 377M 48.09M 42.03M 39.5M 36.05M 67.65M 4.6B 67.67M 474M 183M 2.35B 181M 177M 7.57B |
| Net Debt | 24.02M 28.12M 3.59M 3.13M 2.94M 2.69M 5.04M 343M 5.04M 35.34M 13.64M 175M 13.46M 13.17M 564M | 415M 486M 61.95M 54.14M 50.89M 46.44M 87.15M 5.92B 87.17M 611M 236M 3.02B 233M 228M 9.75B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-09-22 | HK$29.40 | +4.33% | 13,092,800 |
| 26-09-21 | HK$28.18 | +6.90% | 7,276,499 |
| 26-09-18 | HK$26.36 | +1.62% | 5,581,794 |
| 26-09-17 | HK$25.94 | +2.37% | 4,452,600 |
| 26-09-16 | HK$25.34 | -0.94% | 2,290,600 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6185 Stock
Select your edition
All financial news and data tailored to specific country editions
